NCT00883142|Completed
Loading search results
Sponsor study identifier
observational
27
1 country
1
Study Start
October 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2012
Actual (reported)Study Completion
March 2013
Actual (reported)Individuals with neurological deficiencies such as those who have spinal cord injury, stroke, traumatic brain injury, Parkinson's disease, and multiple sclerosis often lose their ability to ambulate over ground. Loss of functional mobility not only impedes everyday life, but may also affect many systems and organs in the body. The investigators are interested in obtaining a wide variety of data in order to obtain a better understanding of changes that occur as a result of receiving Lokomat therapy. The investigators will be studying body composition, cardiac, pulmonary, endocrine, metabolic, and molecular changes after a 12-week clinical therapy program.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 2013
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2006
Date type not reportedThis date has not been verified as actual or estimated.
April 16, 2009
Actual (reported)April 17, 2009
Actual (reported)August 2012
Actual (reported)March 2013
Actual (reported)This pilot study for power calculations on future studies that will characterize the potential benefits of Lokomat rehabilitation training on cardiovascular function, body composition and endocrine/metabolic function
After completion of 24 clinical Lokomat rehabilitation sessions
Lokomat Rehabilitation Clinic
VA Medical Center, Bronx
The Bronx, New York, 10468, United States
Serum, plasma and for some muscle biopsy samples
Ann M. Spungen, EdD
VA Medical Center, Bronx
27 participants (actual enrollment reported by the registry).
First Submitted
April 16, 2009
First Posted
April 17, 2009
Study Start
October 2006
Date type not reportedThis date has not been verified as actual or estimated.
Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.
Contact the study team to confirm eligibility.
Primary Completion
August 2012
Actual (reported)Study Completion
March 2013
Actual (reported)Last Updated
June 11, 2013
Record last verified: 2013-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: